Macquarie Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,967,590
Closed -$50.3M 1660
2023
Q2
$50.3M Sell
1,967,590
-19,765
-1% -$521K 0.06% 427
2023
Q1
$59.1M Buy
1,987,355
+349,799
+21% +$10.2M 0.07% 359
2022
Q4
$44.3M Buy
1,637,556
+122,247
+8% +$2.99M 0.05% 480
2022
Q3
$33M Sell
1,515,309
-6,160
-0.4% -$161K 0.04% 563
2022
Q2
$41.6M Buy
1,521,469
+8,657
+0.6% +$249K 0.05% 518
2022
Q1
$50.7K Sell
1,512,812
-183,196
-11% -$5.9M 0.04% 531
2021
Q4
$58.8M Sell
1,696,008
-29,229
-2% -$945K 0.05% 463
2021
Q3
$53.8M Buy
1,725,237
+76,633
+5% +$2.6M 0.05% 498
2021
Q2
$60M Buy
1,648,604
+157,074
+11% +$6.5M 0.05% 474
2021
Q1
$65.2M Sell
1,491,530
-36,795
-2% -$1.73M 0.09% 269
2020
Q4
$70.1M Sell
1,528,325
-153,600
-9% -$6.39M 0.1% 225
2020
Q3
$55.9M Buy
1,681,925
+14,500
+0.9% +$463K 0.09% 231
2020
Q2
$49M Buy
1,667,425
+112,588
+7% +$3.26M 0.08% 257
2020
Q1
$41.9M Buy
1,554,837
+125,468
+9% +$3.75M 0.09% 249
2019
Q4
$48.2M Buy
1,429,369
+139,900
+11% +$5.07M 0.07% 304
2019
Q3
$48.3M Buy
1,289,469
+54,900
+4% +$2.09M 0.08% 261
2019
Q2
$53.8M Buy
1,234,569
+142,386
+13% +$6.09M 0.09% 245
2019
Q1
$46.6M Buy
1,092,183
+57,177
+6% +$2.56M 0.08% 271
2018
Q4
$46.4M Buy
1,035,006
+136,508
+15% +$7.15M 0.09% 234
2018
Q3
$61.5M Buy
898,498
+873,464
+3,489% +$56.2M 0.1% 208
2018
Q2
$1.43M Sell
25,034
-1,028,509
-98% -$54.3M ﹤0.01% 1095
2018
Q1
$48.5M Buy
1,053,543
+194,262
+23% +$9.22M 0.09% 224
2017
Q4
$39.7M Buy
859,281
+435,935
+103% +$20M 0.07% 281
2017
Q3
$19.1M Buy
+423,346
New +$18.1M 0.03% 462
2016
Q4
Sell
-1,087
Closed -$38K 1534
2016
Q3
$38K Sell
1,087
-1,087
-50% -$38.1K ﹤0.01% 1509
2016
Q2
$70K Buy
2,174
+1,087
+100% +$33.3K ﹤0.01% 1505
2016
Q1
$31K Sell
1,087
-116,300
-99% -$3.1M ﹤0.01% 1486
2015
Q4
$3.92M Hold
117,387
0.01% 759
2015
Q3
$3.34M Buy
117,387
+22,100
+23% +$771K 0.01% 840
2015
Q2
$3.86M Buy
95,287
+94,193
+8,610% +$4.23M 0.01% 830
2015
Q1
$53K Sell
1,094
-668
-38% -$30.9K ﹤0.01% 1513
2014
Q4
$80K Buy
+1,762
New +$69.2K ﹤0.01% 1485

Other funds holding AVNS